Trial Profile
An investigational trial of VIEKIRA with or without ribavirin in pediatric patients with chronic HCV infection
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 30 Jul 2015
Price :
$35
*
At a glance
- Drugs Ombitasvir/paritaprevir/ritonavir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- Sponsors AbbVie
- 30 Jul 2015 New trial record